Editas Medicine Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.1% | -11.8% | -12.6% | -14.9% | +4.3% | -22.8% | -20.1% | -4.2% | -7.5% | -19.9% | +58.9% | |
| – | -5.0% | -10.3% | -6.3% | -5.3% | +6.7% | -22.3% | -18.7% | -3.2% | -7.3% | -21.9% | +70.3% | |
| – | +49.8% | -44.0% | -6.9% | +48.7% | +37.3% | +5.4% | -0.1% | +19.6% | -11.5% | -15.7% | +47.0% | |
| – | -7.6% | -8.3% | -5.8% | -5.0% | +1.8% | -18.1% | -19.2% | -7.2% | -11.5% | -15.7% | +71.2% | |
| – | +320.6% | -97.6% | -0.4% | -48.4% | +12,809.5% | -96.9% | +15.3% | +1,282.7% | +86.7% | -82.9% | +5.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.1% | -2.7% | +4.7% | -0.6% | +36.5% | -2.9% | -4.9% | -1.6% | -15.4% | -9.0% | -8.9% | |
| – | +7.9% | +5.2% | +11.8% | -2.6% | +6.7% | -5.3% | -9.8% | -6.3% | -25.1% | -14.0% | +72.0% | |
| – | +149.3% | -48.9% | +47.2% | -9.8% | -10.6% | -10.2% | -53.3% | -0.9% | +81.2% | +28.7% | -54.1% | |
| – | -20.6% | -3.7% | +72.8% | -9.3% | -56.0% | -0.5% | +23.0% | -53.0% | -17.6% | +66.3% | +9.4% | |
| – | -3.2% | -15.7% | -21.2% | -24.3% | -23.5% | -53.5% | -69.3% | -29.9% | +102.8% | -83.8% | +2,288.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.3% | +0.5% | +0.2% | +0.2% | +0.5% | +1.6% | +6.7% | -1.5% | +10.3% | +21.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.